Chalice Brands Ltd.
CNSX:CHAL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
C
|
Chalice Brands Ltd.
CNSX:CHAL
|
19m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
528.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
275.5B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.8B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
271.4B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.1B USD |
Loading...
|
Market Distribution
| Min | -9 940 586.9% |
| 30th Percentile | -85.9% |
| Median | -7.8% |
| 70th Percentile | 5.5% |
| Max | 60 777.6% |
Other Profitability Ratios
Chalice Brands Ltd.
Glance View
Chalice Brands Ltd. is engaged in the development, processing, and distribution of medical cannabis products. The company is headquartered in Toronto, Ontario. The company went IPO on 2015-10-14. The firm specializes in production, processing, wholesale, distribution and retail, with approximately 12 dispensaries owned and four dispensaries under management in Oregon. The firm is engaged in developing a dynamic portfolio built around the brands of Chalice Farms, with a focus on health and wellness. The firm's products include Private Stash distillate vaporizer cartridges and high dosage single serve Fruit Chew Blast product under both the Golden and Chalice brands. The firm also has a range of spectrum ethanol extract products under the RXO brand and a Live Resin and Distillate vaporizer cartridge under the Elysium Fields brand. The firm operates nationally through Fifth & Root and has operations in Oregon and California.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 10 months, Chalice Brands Ltd.’s Net Margin has increased from -36% to -24.6%. During this period, it reached a low of -43.9% on Mar 31, 2021 and a high of -26.8% on Oct 30, 2021.